Florida · 2026 Regular Session · Bill
SB 844: Sickle Cell Disease Care Management and Treatment Continuing Education
Enacted Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SB 844 is a bill introduced in the Florida Senate on December 10, 2025. According to its official title, it concerns: Sickle Cell Disease Care Management and Treatment Continuing Education. Primary sponsor: Shev Jones (Democratic), Appropriations Committee on Health and Human Services. Most recent recorded action (March 30, 2026): Chapter No. 2026-6.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Sickle Cell Disease Care Management and Treatment Continuing Education; Revising requirements for a continuing education course on prescribing controlled substances which health care practitioners are required to complete, etc.
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Shev Jones | Primary sponsor | Democratic | Senate | 34 |
| Appropriations Committee on Health and Human Services | Primary sponsor | Not applicable (committee) | — | — |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Chapter No. 2026-6
- Approved by Governor
- Signed by Officers and presented to Governor
- Ordered enrolled
- CS passed; YEAS 113, NAYS 0
- Read 3rd time
- Added to Third Reading Calendar
- Read 2nd time
- Bill added to Special Order Calendar (3/11/2026)
- Added to Second Reading Calendar
- Temporarily postponed, on 2nd Reading
- 1st Reading (Committee Substitute 1)
Showing 12 most recent of 34 actions. Full history